Episode 063: Breast Cancer Series, Pt. 8-HER2+, Early Stage Breast Cancer

We continue on our journey through early stage breast cancer, this time turning our attention to HER2+ disease. There is a lot of data in this episode, as you will both hear and see. To make this easier, we highlight key takeaways to make understanding this even easier. Content: - What is HER2? - Discovery of trastuzumab - Data for use of trastuzumab in adjuvant and neoadjuvant setting - Data for use of pertuzumab in adjuvant and neoadjuvant setting - Data and use of trastuzumab emtansine (TDM-1) in the adjuvant setting - Management of HER2+ stage I breast cancer - Highlights of key trials that shape the paradigm of management - Our approach to management ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast